24Sep 2017

THE EFFECT OF DIFFERENT OVARIAN STIMULATION PROTOCOLS ON MULTIFUNCTIONAL FETUIN_A CONCENTRATION IN THE SERUM AND FOLLICULAR FLUID OF WOMEN WITH PCOS UNDERGOING ICSI/IVF.

  • High Institute of Infertility Diagnosis and Assisted Reproductive Technology Al-Nahrain University, Baghdad /Iraq.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: To measure the concentration of fetuin-A in serum and follicular fluid of patients with PCOS at day of ova pick up after using of different IVF/ICSI protocols and to assess the pregnancy outcome. Study design: A total of 90 infertile women (55 women with Polycystic ovary syndrome and the other 35 women as a control (non PCOS) undergoing controlled ovarian hyperstimulation for intracytoplasmic sperm injection cycle were prospectively recruited for this study in High Institute of Infertility Diagnosis and Assisted Reproductive Technology / AL-Nahrian University and Kamal AL-Samarai Hospital, center of fertility and IVF (Baghdad/Iraq) during the period from December 2015 to the end of April 2017.The fifty five PCOS women were divided into three groups: twenty five (25) infertile women have had PCOS undergoing long Agonist protocol for ICSI cycle, fifteen (15) infertile women have had PCOS undergoing Antagonist protocol for ICSI and fifteen (15) infertile women have had PCOS undergoing short Agonist protocol for ICSI. The controlled group included 35 women were free of signs and symptoms of PCOS with regular cycles and no endocrine abnormalities undergoing ICSI cycle (15 infertile women underwent long agonist protocol, 10 women underwent short agonist and 10 women underwent antagonist protocol). In all patients, serum and follicular fluid fetuin-A levels were measured on the day of oocyte retrieval by using Enzyme linked immuno sorbent assay. Results: There was significant difference (p<0.05) in the level of fetuin-A in follicular fluid between PCOS and control group. Follicular fluid fetuin-A level was high in non PCOS patients than PCOS patients but no significant difference (p>0.05) in the level of fetuin-A in serum between PCOS and control group. Also there was no significant difference in the effect of different IVF/ICSI protocols (Long agonist, Antagonist, Short agonist) in the level of follicular & serum fetuin-A of patients with PCOS (P>0.05) and no significant difference (P>0.05) in level of serum and follicular fluid fetuin-A between pregnant &non pregnant PCOS patients. žConclusion: It was concluded from the present study that FF fetuin- A concentration of PCOS patients at the day of oocyte retrieval is significantly lower than that of non PCOS patient. But no significant ž difference in S-Fetuin A concentration between PCOS and non PCOS patients, no significant difference in the effect of different IVF protocols on serum and follicular Fetuin A and no significant difference in S-FA and FF-FA between pregnant and non- pregnant PCOS patients underwent IVF protocols.

  1. Byneil S and Charissa M. Polycystic Ovary Syndrome. Obstet. Gynecol. 2009; 114:936-49.
  2. Peitsidis, R. AgrawalRole of vascular endothelial growth factor in women with PCO and PCOS: a systematic review. Reprod Biomed Online, 20 (2010), pp. 444?452.
  3. Lim SS, Norman RJ, Davies MJ et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013; 14: 95?109.
  4. Song AY, Xu M, Bi YF, et al. Serum Fetuin-A Associates with Type2 Diabetes and Insulin Resistance in Chinese Adults. PLOS One2011; 6: e19228.
  5. T. Mathews, P.R. Srinivas, M.A. Leon, G. Grunberger. Bovine Fetuin is an inhibitor of insulin?????? receptor tyrosine kinase.? Life Sci., 61 (1997), pp. 1583?1592.
  6. Srinivas PR, Wagner AS, Reddy LV et al. Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol 1993; 7: 1445?1455.
  7. Stefan, A.M. Hennige, H. Staiger, J. Machann, F. Schick, S.M. Krober, F. Machicao, A. Fritsche, H.U. H?ring. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care, 2006; 29 pp. 853?857.
  8. Mori?K, Emoto?M, Yokoyama?H, et al.??Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects.??Diabetes Care.?2006; 29 (2):468.
  9. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to Polycystic ovary syndrome (PCOS), Hum Reprod 19 .2004; pp. 41?47, Fertile Steril.; 81: 19-25. 11.
  10. Hugues JN, C?drin-Durnerin I. Endocrine characteristics of ART Cycles. In : Gradner DK, Weissman A, Howles CM, Shoham Z ,editors. Textbook of Assisted Reproductive Technologies, Volume Two: Clinical Perspective.4th ed. London: Informa Health care; 2012. pp. 99-114.
  11. Elder K, Dale B. In-Vitro3rded. New York: Cambridge University Press. 2011. pp.19-27.
  12. Zegers-Hochschild F, Adamson GD, de Mouzon J, et al. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology.2009. Hum. Reprod. 2009; 24: 2683-7. 87.
  13. Al-Inany H, and Aboulghar M. GnRH antagonist in assisted reproduction:a Cochrane review. Hum Reprod. 2002; 17:874?885.
  14. Schats R, Huirne JAF. The use of GnRH agonists. In : Gradner DK, Weissman A, Howles CM, Shoham Z, editors. Textbook of Assisted Reproductive Technologies, Volume Two: Clinical Perspectives, 4th ed.London: Informa Health care. 2012. pp.115-23.
  15. 2012. Statistical Analysis System, User's Guide. Statistical. Version 9.1th ed. SAS. Inst. Inc. Cary. N.C. USA.
  16. Stefan N, Fritsche A, Weikert C et al. Plasma fetuin-A levels and the riskof type 2 diabetes. Diabetes 2008; 57: 2762?2767.
  17. Srinivas PR, Goustin AS, Grunberger G. Baculoviral expression of a natural inhibitor of the human insulin receptor tyrosine kinase. Biochem Biophys Res Commun 1995; 208: 879?885.
  18. Carmina E, Lobo RA. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2004; 82: 661?665.
  19. Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B et al.Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome. Endokrynol Pol. 2005; 6: 921?926.
  20. Hamilton-Fairley D, Kiddy D, Watson H et al. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol .1992; 99: 128?131.
  21. Brix JM, Stingl H, H?ller F et al. Elevated Fetuin-A Concentration in Morbid Obesity Decrease after Dramatic Weight Loss. J Clin Endocrinol Metab 2010; 95: 4877?4881.
  22. Abali R, Celik C, Tasdemir N et al. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-A concentration and caroid intima-media thickness in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2013; 169: 45?49.
  23. Gulhan I, Bozkaya G, Ozetkin D et al. Serum Fetuin-A levels in women with polycystic ovary syndrome. Arch Gynecol Obstet 2012; 286: 1473?1476.
  24. Yaşar Enli,?Semin Fenkci, Veysel Fenkci, ?Ozer Oztekin. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome. Gynecol Endocrinol, 2013;29(12)1036-1039.
  25. Antoaneta G, Zdravko K, Adelina T. MCP-1 and fetuin A levels in patients with PCOSand/or obesity before and after metformin treatmentCent. Eur. J. Med. 2013; 8(5): 679-684.

[Nada Flayyih Hasan AL-Aboudy, Nawal Khairy Hussain AL- Ani and Ula Mohammed Reda AlKawaz. (2017); THE EFFECT OF DIFFERENT OVARIAN STIMULATION PROTOCOLS ON MULTIFUNCTIONAL FETUIN_A CONCENTRATION IN THE SERUM AND FOLLICULAR FLUID OF WOMEN WITH PCOS UNDERGOING ICSI/IVF. Int. J. of Adv. Res. 5 (Sep). 1012-1019] (ISSN 2320-5407). www.journalijar.com

NADA FLAYYIH HASAN
INFERTILITY SPECIALIST

DOI:

Article DOI: 10.21474/IJAR01/5418      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5418

Download Full Paper

Download PDF No. of Downloads: 9 | No. of Views: 71